Maxpro Capital Acquisition (JMAC) Stock Price, News & Analysis

Company Overview

Maxpro Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Taipei City, Taiwan.

Key Stats

• Today's Range: $0.14 to $0.16
• 50-Day Range: $0.10 to $10.81
• 52-Week Range: $7.50 to $19.22
• Volume: 9.66 million shs
• Average Volume: 74,040 shs
• Market Capitalization: $2.01 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

JMAC Stock Analysis - Frequently Asked Questions

How have JMAC shares performed this year?

Maxpro Capital Acquisition's stock was trading at $0.9650 at the beginning of the year. Since then, JMAC stock has decreased by 84.5% and is now trading at $0.1498.
View the best growth stocks for 2024 here.

How do I buy shares of Maxpro Capital Acquisition?

Shares of JMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Maxpro Capital Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Maxpro Capital Acquisition investors own include Meta Platforms (META), PhaseBio Pharmaceuticals (PHAS), Dermata Therapeutics (DRMA), Daifuku (DAIUF), CXApp (CXAI), Centogene (CNTG) and China Jo-Jo Drugstores (CJJD).

Company Calendar

• Today: 11/20/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Unclassified
• Industry: Holding & other investment offices
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:JMAC
• CUSIP: N/A
• CIK: 1874259
• Web: N/A
• Phone: 886-2-7713-7952
• Fax: N/A
• Employees: 2,021
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 13,428,000
• Free Float: 10,840,000
• Market Cap: $2.01 million
• Optionable: Not Optionable
• Beta: 0.01